Stephen Gucker

Array ( [id] => 1477669 [patent_doc_number] => 06451570 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Mutants of monoamine oxidase B' [patent_app_type] => B1 [patent_app_number] => 09/265653 [patent_app_country] => US [patent_app_date] => 1999-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7234 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451570.pdf [firstpage_image] =>[orig_patent_app_number] => 09265653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376177 [patent_doc_number] => 06277377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Human phosphodiesterase regulatory subunit' [patent_app_type] => 1 [patent_app_number] => 9/255045 [patent_app_country] => US [patent_app_date] => 1999-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18339 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277377.pdf [firstpage_image] =>[orig_patent_app_number] => 255045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589215 [patent_doc_number] => 06482796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-19 [patent_title] => 'Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients' [patent_app_type] => B2 [patent_app_number] => 09/255245 [patent_app_country] => US [patent_app_date] => 1999-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7490 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482796.pdf [firstpage_image] =>[orig_patent_app_number] => 09255245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596158 [patent_doc_number] => 06384206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis ' [patent_app_type] => B1 [patent_app_number] => 09/247137 [patent_app_country] => US [patent_app_date] => 1999-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 5826 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384206.pdf [firstpage_image] =>[orig_patent_app_number] => 09247137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254216 [patent_doc_number] => 06207799 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Neuropeptide Y receptor Y5 and nucleic acid sequences' [patent_app_type] => 1 [patent_app_number] => 9/235839 [patent_app_country] => US [patent_app_date] => 1999-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 9074 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207799.pdf [firstpage_image] =>[orig_patent_app_number] => 235839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4273715 [patent_doc_number] => 06280971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Polynucleotides encoding GTP cyclohydrolase II (RIBA)' [patent_app_type] => 1 [patent_app_number] => 9/227806 [patent_app_country] => US [patent_app_date] => 1999-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15496 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280971.pdf [firstpage_image] =>[orig_patent_app_number] => 227806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4401640 [patent_doc_number] => 06171598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'GTP cyclohydrolase II (RIBA)' [patent_app_type] => 1 [patent_app_number] => 9/225967 [patent_app_country] => US [patent_app_date] => 1999-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14084 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171598.pdf [firstpage_image] =>[orig_patent_app_number] => 225967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1268643 [patent_doc_number] => 06652864 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Compounds for intracellular delivery of therapeutic moieties to nerve cells' [patent_app_type] => B1 [patent_app_number] => 09/217037 [patent_app_country] => US [patent_app_date] => 1998-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6044 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/652/06652864.pdf [firstpage_image] =>[orig_patent_app_number] => 09217037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308453 [patent_doc_number] => 06316206 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Method for screening comprising cells expressing the CNTF receptor' [patent_app_type] => 1 [patent_app_number] => 9/211590 [patent_app_country] => US [patent_app_date] => 1998-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 21594 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316206.pdf [firstpage_image] =>[orig_patent_app_number] => 211590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308405 [patent_doc_number] => 06316203 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)' [patent_app_type] => 1 [patent_app_number] => 9/200673 [patent_app_country] => US [patent_app_date] => 1998-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 45 [patent_no_of_words] => 45558 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316203.pdf [firstpage_image] =>[orig_patent_app_number] => 200673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292320 [patent_doc_number] => 20020055617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'CLONING AND RECOMBINANT PRODUCTION OF CFR RECEPTOR(S)' [patent_app_type] => new [patent_app_number] => 09/191724 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20922 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055617.pdf [firstpage_image] =>[orig_patent_app_number] => 09191724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1296970 [patent_doc_number] => 06627440 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'Recombinant human alpha-fetoprotein as a cell proliferative agent' [patent_app_type] => B1 [patent_app_number] => 09/187978 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8937 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627440.pdf [firstpage_image] =>[orig_patent_app_number] => 09187978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548487 [patent_doc_number] => 06399064 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Cloning and regulation of an endothelial cell protein C/activated protein C receptor' [patent_app_type] => B1 [patent_app_number] => 09/182616 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 9435 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399064.pdf [firstpage_image] =>[orig_patent_app_number] => 09182616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1412052 [patent_doc_number] => 06511666 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Diagnostics and treatments of periodontal disease' [patent_app_type] => B1 [patent_app_number] => 09/066330 [patent_app_country] => US [patent_app_date] => 1998-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 13 [patent_no_of_words] => 22184 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511666.pdf [firstpage_image] =>[orig_patent_app_number] => 09066330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1487484 [patent_doc_number] => 06428965 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Screening assays for the interaction of semaphorins and neuropilins' [patent_app_type] => B1 [patent_app_number] => 09/116473 [patent_app_country] => US [patent_app_date] => 1998-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 27 [patent_no_of_words] => 12252 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428965.pdf [firstpage_image] =>[orig_patent_app_number] => 09116473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478387 [patent_doc_number] => 06344544 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Semaphorin-specific antibodies' [patent_app_type] => B1 [patent_app_number] => 09/060610 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33215 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344544.pdf [firstpage_image] =>[orig_patent_app_number] => 09060610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4024482 [patent_doc_number] => 05925740 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Antibodies to receptor for oncostatin M' [patent_app_type] => 1 [patent_app_number] => 9/059099 [patent_app_country] => US [patent_app_date] => 1998-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22799 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925740.pdf [firstpage_image] =>[orig_patent_app_number] => 059099 [rel_patent_id] =>[rel_patent_doc_number] =>)